Drugs / DEXVERAPAMIL
DEXVERAPAMIL
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02209155 Comparator | Nov 2013 → Mar 2018 | cluster headache syndrome | Center Laboratories, Inc. | Terminated | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DEXVERAPAMIL | ChEMBL registry synonym — accepted as the source's own label CHEMBL197 ↗ |
| Known as | D-verapamil | ChEMBL registry synonym — accepted as the source's own label CHEMBL197 ↗ |
| Known as | Dexverapamilo | ChEMBL registry synonym — accepted as the source's own label CHEMBL197 ↗ |
| Known as | R-verapamil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02209155 ↗ |
| Known as | Verapamil (r)-form | ChEMBL registry synonym — accepted as the source's own label CHEMBL197 ↗ |
| Modality | Small molecule | — CHEMBL197 ↗ |